The robustness of DLP® hyperspectral imaging for clinical and surgical utility

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 7596, Issue , 2010, Pages

  Zuzak, Karel J ^a   Wehner, Eleanor ^a   Rao, Shekar ^b   Litorja, Maritoni ^c   Allen, David W ^c   Singer, Mike ^d   Purdue, Gary ^d   Ufret Vincenty, Rafael ^d   White, Jonathan ^d   Cadeddu, Jeffrey ^d   Livingston, Edward ^d  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^b TEXAS INSTRUMENTS   (United States)

^c NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Clinical applications; DLP; DMD; Hyperspectral imaging

Indexed keywords

CHEMOMETRICES; CLINICAL APPLICATION; COLOR-ENCODED; DECONVOLUTION METHOD; DISEASED TISSUES; GRAY SCALE; HYPERSPECTRAL IMAGING; HYPERSPECTRAL IMAGING SYSTEMS; ILLUMINATION SOURCES; MOLECULAR CONSTITUENTS; OPTICAL SPECTRA; SPECTRALLY TUNABLE; SPECTROSCOPIC IMAGES; SURGICAL PROCEDURES; TEXAS INSTRUMENTS; VIDEO RATES;

OPTOELECTRONIC DEVICES;

EID: 77951519971     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.845564     Document Type: Conference Paper

References (9)

1. Zuzak, K.J.; Naik, S.C.; Alexandrakis, G.; Hawkins, D.; Behbehani, K.; Livingston, E., "Characterization of a Near-Infrared Laproscopic Hyperspectral Imaging System for Minimally Invasive Surgery," Anal. Chem., 79, 4709-4715 (2007). (Pubitemid 46999591)
2. Zuzak, K.J.; Schaeberle, M.D.; Gladwin, M.T.; Cannon, R.O.; Levin, I.W., "Noninvasive determination of spatially resolved and time-resolved tissue perfusion in humans during nitric oxide inhibition and inhalation by use of a visible-reflectance hyperspectral imaging technique." Circulation, 104, 2905-2910 (2001).
3. Zuzak, K.J.; Gladwin, M.T.; Cannon, R.O.; Levin, I.W., "Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: effects of nitric oxide." Am J. Physiol: Heart Circulatory Physiol, 285, H1183-1189 (2003).
4. Zuzak, K.J.; Schaeberle, M.D.; Lewis, E.N.: Levin, I.W., "Visible Reflectance Hyperspectral Imaging: Characterization of a Noninvasive, in vivo System for Determining Tissue Perfusion," Anal. Chem, 74, 2021-2028 (2002).
5. Zuzak, K.J.; Schaeberle, M.D.; Lewis, E.N.: Levin, I.W., "Visible Spectroscopic Imaging Studies of Normal and Ischemic Dermal Tissue," Proc. SPIE, 3918,17-26 (2000).
6. Zuzak, K.J.; Schaeberle, M.D.; Levin, I.W.; Lewis, N.E.; Freeman, J.; McNeil, J.D.; Cancio, L.C., "Visible and infrared hyperspectral visualization of normal and ischemic tissue" IEEE, 2, 1118 (1999).
7. Fong, A.; Bronson, B.; Wachman, E.; "Advanced photonic tools for hyperspectral imaging in the life science" SPIE Newsroom, doi: 10.1117/2.1200803.1051 (2008).
8. American Cancer Society. Cancer Facts and Figures 2009. Atlanta, Ga: American Cancer Society; 2009.
9. Zuzak K.J., Francis R., Wehner E., Smith J., Litorja M., Allen D., Tracy C., Cadeddu J., Livingston E.. DLP hyperspectral imaging for surgical and clinical utility. SPIE conference proceedings, Jan (2009).